Last Updated:
Searching
Create account to add to watchlist!

Tuatara Capital Acquisition Corp - TCAC

  • Commons

    $9.90

    +0.10%

    TCAC Vol: 12.0

  • Warrants

    $0.75

    +0.00%

    TCACW Vol: 0.0

  • Units

    $10.13

    -1.17%

    TCACU Vol: 0.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 198.0M
Average Volume: 152.6K
52W Range: $9.60 - $10.12
Weekly %: +0.25%
Monthly %: +1.72%
Inst Owners: 2

Info

Target: Searching
Days Since IPO: 289
Unit composition:
Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant
Trust Size: 15000000.0M

Management

Officers and Directors 128 Table of Contents Upon the effectiveness of the registration statement of which this prospectus forms a part, we expect that our board of directors will consist of five members. Our board of directors is divided into two classes with only one class of directors being elected in each year and each (except for those directors appointed prior to our first annual general meeting) serving a two-year term. The term of office of the first class of directors will expire at our first annual general meeting and the term of office of the second class of directors will expire at our second annual general meeting. We may not hold an annual general meeting until after we consummate our initial business combination (unless required by Nasdaq). Subject to any other special rights applicable to the shareholders, any vacancies on our board of directors may be filled by the affirmative vote of a majority of the directors present and voting at the meeting of our board or by a majority of the holders of our ordinary shares (or, prior to our initial business combination, holders of our founder shares). Our officers are elected by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate. Our amended and restated memorandum and articles of association will provide that our officers may consist of a Chairman, a Chief Executive Officer, a President, a Chief Operating Officer, a Chief Financial Officer, Vice Presidents, a Secretary, Assistant Secretaries, a Treasurer and such other offices as may be determined by the board of directors. Director Independence Nasdaq listing standards require that a majority of our board of directors be independent within one year of our initial public offering. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that Jeffrey Bornstein, Richard Taney and Aris Kekedjian are “independent directors” as defined in the Nasdaq listing standards and applicable SEC rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Officer and Director Compensation None of our officers or directors have received or, prior to our initial business combination, will receive any cash compensation for services rendered to us. We will pay our sponsor up to $10,000 per month for office space, administrative and support services. Our sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. In connection with the closing of this offering, our sponsor intends to grant sponsor LLC equity interests to our independent directors and director nominees that collectively comprise approximately % of the outstanding equity interests in our sponsor. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or any of their affiliates. After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting, management or other compensation from the combined company. All compensation will be fully disclosed to shareholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination. It is unlikely the amount of such compensation will be known at the time, because the directors of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our officers after the completion of our initial business combination will be determined by a compensation committee constituted solely by independent directors. We are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment. The existence or terms of any such employment or consulting arrangements may influence our management’s motivation in identifying or selecting a target business, and we do not believe that the ability of our management to remain with us after the completion of our initial business combination should be a determining factor in our decision to proceed with any potential business combination. 129 Table of Contents Committees of the Board of Directors We will establish three standing committees - an audit committee in compliance with Section 3(a)(58)(A) of the Exchange Act, a compensation committee and a nominating committee, each comprised of independent directors. Audit Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish an audit committee of the board of directors. The members of our audit committee will be Jeffrey Bornstein, Richard Taney and Aris Kekedjian. will serve as chairman of the audit committee. Each member of the audit committee is financially literate and our board of directors has determined that qualifies as an “audit committee financial expert” as defined in applicable SEC rules and has accounting or related financial management expertise. We will adopt an audit committee charter, which will detail the purpose and principal functions of the audit committee, including: · assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public accounting firm’s qualifications and independence and (4) the performance of our internal audit function and independent registered public accounting firm; · the appointment, compensation, retention, replacement and oversight of the work of the independent registered public accounting firm and any other independent registered public accounting firm engaged by us; · pre-approving all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered public accounting firm engaged by us and establishing pre-approval policies and procedures; · reviewing and discussing with the independent registered public accounting firm all relationships the auditors have with us in order to evaluate their continued independence; · setting clear hiring policies for employees or former employees of the independent registered public accounting firm; · setting clear policies for audit partner rotation in compliance with applicable laws and regulations; · obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent registered public accounting firm’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; · meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent registered public accounting firm, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; · reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and · reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. 130 Table of Contents Compensation Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish a compensation committee of the board of directors. The members of our Compensation Committee will be Jeffrey Bornstein, Richard Taney and Aris Kekedjian. will serve as chairman of the compensation committee. We will adopt a compensation committee charter, which will detail the purpose and responsibility of the compensation committee, including: · reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; · reviewing and making recommendations to our board of directors with respect to the compensation and any incentive-compensation and equity-based plans that are subject to board approval of all of our other officers; · reviewing our executive compensation policies and plans; · implementing and administering our incentive compensation equity-based remuneration plans; · assisting management in complying with our proxy statement and annual report disclosure requirements; · approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; · producing a report on executive compensation to be included in our annual proxy statement; and · reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. The charter will also provide that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC. Nominating Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish a nominating committee of the board of directors. The members of our nominating committee will be Jeffrey Bornstein, Richard Taney and Aris Kekedjian. will serve as chair of the nominating committee. We will adopt a nominating committee charter, which will detail the purpose and responsibilities of the nominating committee, including: · identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the board, and recommending to the board of directors candidates for nomination for election at the annual general meeting or to fill vacancies on the board of directors; · developing and recommending to the board of directors and overseeing implementation of our corporate governance guidelines; · coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance of the company; and · reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary. 131 Table of Contents The charter will also provide that the nominating committee may, in their sole discretion, retain or obtain the advice of, and terminate, any search firm to be used to identify director candidates, and will be directly responsible for approving the search firm’s fees and other retention terms. We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders. Compensation Committee Interlocks and Insider Participation None of our officers currently serves, and in the past year has not served, as a member of the board of directors or compensation committee of any entity that has one or more officers serving on our board of directors. Code of Ethics Prior to the effectiveness of the registration statement of which this prospectus is a part, we will have adopted a code of ethics applicable to our directors, officers and employees (our “Code of Ethics”). Our Code of Ethics will be available on our website upon the completion of this offering. Our Code of Ethics is a “code of ethics,” as defined in Item 406(b) of Regulation S-K. We will make any legally required disclosures regarding amendments to, or waivers of, provisions of our Code of Ethics on our website. Conflicts of Interest All of our executive officers and certain of our directors have or may have fiduciary and contractual duties to certain companies in which they have invested. These entities may compete with us for acquisition opportunities. If these entities decide to pursue any such opportunity, we may be precluded from pursuing it. However, we do not expect these duties to present a significant conflict of interest with our search for an initial business combination. Under Cayman Islands law, directors and officers owe the following fiduciary duties: · duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; · duty to exercise authority for the purpose for which it is conferred; · duty to not improperly fetter the exercise of future discretion; · duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and · duty to exercise independent judgment. In addition to the above, directors also owe a duty of care, which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge, skill and experience which that director has. As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position at the expense of the company. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders; provided that there is full disclosure by the directors. This can be done by way of permission granted in the amended and restated memorandum and articles of association or alternatively by shareholder approval at general meetings. 132 Table of Contents Certain of our officers and directors presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity that is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she may need to honor these fiduciary or contractual obligations to present such business combination opportunity to such entity, subject to their fiduciary duties under Cayman Islands law. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our initial business combination. Potential investors should also be aware of the following potential conflicts of interest: · None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities. · In the course of their other business activities, our officers and directors may become aware of investment and business opportunities that may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented. For a complete description of our management’s other affiliations, see “—Directors, Director Nominees and Executive Officers.” · Our initial shareholders have agreed to waive their redemption rights with respect to their founder shares and any public shares held by them in connection with the completion of our initial business combination. Our directors and officers have also entered into the letter agreement, imposing similar obligations on them with respect to public shares acquired by them, if any. Additionally, our initial shareholders have agreed to waive their redemption rights with respect to their founder shares if we fail to consummate our initial business combination within 24 months after the closing of this offering. However, if our initial shareholders or any of our officers, directors or affiliates acquire public shares in or after this offering, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to consummate our initial business combination within the prescribed time frame. If we do not complete our initial business combination within such applicable time period, the proceeds of the sale of the private placement warrants held in the trust account will be used to fund the redemption of our public shares, and the private placement warrants will expire worthless. With certain limited exceptions, the founder shares will not be transferable, assignable or salable by our initial shareholders until the earlier of (1) one year after the completion of our initial business combination and (2) subsequent to our initial business combination, (x) if the last reported sale price of our ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination or (y) the date on which we consummate a liquidation, merger, amalgamation, share exchange, reorganization, or other similar transaction that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. With certain limited exceptions, the private placement warrants and the Class

Holder Stats

1 0
% of Shares Held by All Insider 0.00%
% of Shares Held by Institutions 5.14%
% of Float Held by Institutions 5.14%
Number of Institutions Holding Shares 2

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-16 Schonfeld Strategic Advisors LLC 28,586 $280,000 0.0% +8.8% 0.468%
2021-11-16 Jane Street Group LLC 186,084 $1,810,000 0.0% +12.3% 3.048%
2021-11-16 Whitebox Advisors LLC 73,000 $710,000 0.0% +46.0% 1.196%
2021-11-16 Citadel Advisors LLC 150,000 $1,460,000 0.0% 0 2.457%
2021-11-16 CNH Partners LLC 86,650 $840,000 0.0% +128.0% 1.419%
2021-11-16 Castle Creek Arbitrage LLC 851,460 $8,279,999 0.5% 0 13.945%
2021-11-15 Berkley W R Corp 44,378 $430,000 0.0% +125.8% 0.727%
2021-11-15 Marshall Wace LLP 861,251 $8,380,000 0.0% 0 14.105%
2021-11-15 Hudson Bay Capital Management LP 412,104 $4,010,000 0.1% -2.4% 6.749%
2021-11-15 Context Advisory LLC 125,412 $1,220,000 0.1% 0 2.054%
2021-11-15 Dark Forest Capital Management LP 202,389 $1,970,000 0.7% 0 3.315%
2021-11-15 HighTower Advisors LLC 185,813 $1,810,000 0.0% +11.1% 3.043%
2021-11-12 PEAK6 Investments LLC 155,493 $1,510,000 0.0% +3.7% 2.547%
2021-11-12 Periscope Capital Inc. 771,800 $7,510,000 0.2% +22.5% 12.640%
2021-11-12 Arena Capital Advisors LLC CA 253,352 $2,470,000 0.2% +200.7% 4.149%
2021-11-12 Wolverine Asset Management LLC 21,396 $210,000 0.0% +1,800.2% 0.350%
2021-11-10 Healthcare of Ontario Pension Plan Trust Fund 75,000 $730,000 0.0% 0 1.228%
2021-11-09 Basso Capital Management L.P. 114,817 $1,120,000 0.1% +5.5% 1.879%
2021-08-17 Aristeia Capital LLC 1,038,023 $10,070,000 0.2% 0 17.000%
2021-08-17 Boothbay Fund Management LLC 14,326 $150,000 0.0% 0 0.235%
2021-08-17 Caas Capital Management LP 100,000 $970,000 0.0% 0 1.638%
2021-08-16 Whitebox Advisors LLC 50,000 $490,000 0.0% 0 0.819%
2021-08-16 CNH Partners LLC 38,000 $370,000 0.0% 0 0.622%
2021-08-16 Bank of America Corp DE 125,153 $1,210,000 0.0% 0 2.050%
2021-08-16 LMR Partners LLP 315,869 $3,060,000 0.0% 0 5.173%
2021-08-16 Berkley W R Corp 19,650 $190,000 0.0% 0 0.322%
2021-08-16 Fir Tree Capital Management LP 100,000 $970,000 0.0% 0 1.638%
2021-08-16 Alyeska Investment Group L.P. 800,000 $7,760,000 0.1% 0 13.102%
2021-08-16 Schonfeld Strategic Advisors LLC 26,276 $260,000 0.0% 0 0.430%
2021-08-16 Telemetry Investments L.L.C. 120,915 $1,170,000 1.6% 0 1.980%
2021-08-16 Polygon Management Ltd. 100,000 $970,000 0.1% 0 1.638%
2021-08-16 Radcliffe Capital Management L.P. 500,000 $4,850,000 0.2% 0 8.189%
2021-08-16 Bloom Tree Partners LLC 19,499 $190,000 0.0% 0 0.319%
2021-08-16 Goldman Sachs Group Inc. 626,829 $6,080,000 0.0% 0 10.266%
2021-08-16 Periscope Capital Inc. 630,000 $6,110,000 0.2% 0 10.318%
2021-08-13 Ancora Advisors LLC 15,200 $150,000 0.0% 0 0.249%
2021-08-13 Basso Capital Management L.P. 108,843 $1,060,000 0.1% 0 1.783%
2021-08-13 PEAK6 Investments LLC 149,997 $1,460,000 0.0% 0 2.457%
2021-08-13 Geode Capital Management LLC 11,671 $110,000 0.0% 0 0.191%
2021-08-12 MMCAP International Inc. SPC 200,000 $1,940,000 0.1% 0 3.275%
2021-08-12 Bank of Montreal Can 304,884 $2,960,000 0.0% 0 4.993%
2021-08-11 Arena Capital Advisors LLC CA 84,256 $820,000 0.1% 0 1.380%
2021-08-11 Picton Mahoney Asset Management 200,000 $1,940,000 0.1% 0 3.275%
2021-08-11 CVI Holdings LLC 700,000 $6,780,000 0.5% 0 11.464%
2021-08-06 HighTower Advisors LLC 167,288 $1,620,000 0.0% 0 2.740%
2021-08-03 Landscape Capital Management L.L.C. 15,121 $150,000 0.0% 0 0.248%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q 10-Q 2021-11-12 https://www.sec.gov/Archives/edgar/data/1801602/000114036121037686/brhc10030478_10q.htm
425 425 2021-11-09 https://www.sec.gov/Archives/edgar/data/1801602/000114036121037119/ny20001241x1_8k.htm
8-K 8-K 2021-11-09 https://www.sec.gov/Archives/edgar/data/1801602/000114036121037117/ny20001241x1_8k.htm
8-K FORM 8-K 2021-08-27 https://www.sec.gov/Archives/edgar/data/1801602/000095010321013069/dp156636_8k.htm
10-Q 10-Q 2021-08-16 https://www.sec.gov/Archives/edgar/data/1801602/000114036121028318/brhc10027773_10q.htm
10-Q 10-Q 2021-06-03 https://www.sec.gov/Archives/edgar/data/1801602/000114036121019768/brhc10025208_10q.htm
8-K FORM 8-K 2021-05-28 https://www.sec.gov/Archives/edgar/data/1801602/000095010321008141/dp151989_8k.htm
4 FORM 4 2021-05-19 https://www.sec.gov/Archives/edgar/data/1801602/000095010321007510/xslF345X03/dp151381_4-tcac.xml
NT 10-Q FORM NT 10-Q 2021-05-17 https://www.sec.gov/Archives/edgar/data/1801602/000095010321007350/dp151142_nt10q.htm
8-K FORM 8-K 2021-04-23 https://www.sec.gov/Archives/edgar/data/1801602/000095010321005997/dp1490834_8k.htm
8-K FORM 8-K 2021-04-02 https://www.sec.gov/Archives/edgar/data/1801602/000095010321005129/dp149002_8k.htm
SC 13G TUATARA CAPITAL ACQUISITION CORPORATION 2021-03-01 https://www.sec.gov/Archives/edgar/data/1801602/000090266421001650/p21-0846sc13g.htm
8-K FORM 8-K 2021-02-23 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002801/dp146579_8k.htm
SC 13G 2021-02-22 https://www.sec.gov/Archives/edgar/data/1801602/000131924421000144/TCAC_SC13G.htm
8-K FORM 8-K 2021-02-17 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002403/dp146234_8k.htm
424B4 FORM 424B4 2021-02-16 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002329/dp146157_424b4.htm
EFFECT 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/999999999521000608/xslEFFECTX01/primary_doc.xml
3 FORM 3 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002198/xslF345X02/dp146047_3-bornstein.xml
3 FORM 3 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002197/xslF345X02/dp146050_3-foreman.xml
3 FORM 3 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002196/xslF345X02/dp146048_3-sherman.xml
3 FORM 3 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002195/xslF345X02/dp146052_3-taney.xml
3 FORM 3 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002194/xslF345X02/dp146049_3-zittman.xml
3 FORM 3 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002193/xslF345X02/dp146051_3-kekedjian.xml
3 FORM 3 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002192/xslF345X02/dp146053_3-tcac.xml
S-1MEF FORM S-1MEF 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002189/dp145993_s1mef.htm
CERT 2021-02-11 https://www.sec.gov/Archives/edgar/data/1801602/000135445721000216/8A_Cert_TCAC.pdf
8-A12B FORM 8-A12B 2021-02-10 https://www.sec.gov/Archives/edgar/data/1801602/000095010321002070/dp145942_8a12b.htm
S-1/A FORM S-1/A 2021-02-04 https://www.sec.gov/Archives/edgar/data/1801602/000095010321001827/dp145618_s1a.htm
S-1 FORM S-1 2021-01-27 https://www.sec.gov/Archives/edgar/data/1801602/000095010321001084/dp144889_s1.htm
DRS/A 2020-11-10 https://www.sec.gov/Archives/edgar/data/1801602/000095010320021937/filename1.htm
DRS/A 2020-08-12 https://www.sec.gov/Archives/edgar/data/1801602/000095010320015718/filename1.htm
DRS/A 2020-05-14 https://www.sec.gov/Archives/edgar/data/1801602/000095010320009542/filename1.htm
DRS 2020-02-14 https://www.sec.gov/Archives/edgar/data/1801602/000095010320002789/filename1.htm